艾纳香黄酮类化学成分的研究(英文)

从艾纳香(Blumea balsamiferaDC.)的地上部分中分离得到13个黄酮类化合物,经鉴定分别为5,7-二羟基-3,3′,4′-三甲氧基黄酮(1),3,5,3′,4′-四羟基-7-甲氧基黄酮(2),4,2′,4′-三羟基双氢查尔酮(3),儿茶素(4),阿亚黄素(5),davidioside(6),二氢槲皮素-7,4′-二甲醚(7),艾纳香素(8),二氢槲皮素-4′-甲醚(9),3,5,3′-三羟基-7,4′-二甲氧基黄酮(10),5,7,3′,5′-四羟基二氢黄酮(11),木犀草素(12),槲皮素(13)。其中化合物1和3~6为首次从该植物中分离得到。     

千里香化学成分研究CSCD

研究千里香的化学成分。采用硅胶、ODS、Sephadex LH-20、制备液相等多种色谱分离技术进行分离纯化,通过波谱数据分析进行结构鉴定。从千里香70%乙醇提取物中分离得到26个化合物,分别鉴定为千里香脂素(1)、8-去甲基川陈皮素(2)、ficusal(3)、lariciresinol-4′-monomethy ether(4)、(±)-5′-methoxy-4′-O-methyllariciresinol(5)、diospyrosin(6)、(-)-9′-O-E-feruloyl-lyoniresinol(7)、7-O-methylphellodenol-B(8)、欧芹烯酮酚甲醚(9)、3,4′-二羟基-3′,5′-二甲氧基苯丙酮(10)、4′-羟基-5,7-二甲氧基二氢黄酮(11)、5-羟基-6,7,3′,4′-四甲氧基二氢黄酮(12)、4′-羟基-5,7,3′-三甲氧基二氢黄酮(13)、5,7,3′,4′,5′-五甲氧基二氢黄酮(14)、2′,4-二羟基-3′,4′,6′-三甲氧基查尔酮(15)、2′,3-二羟基-4,4′,6′-三甲氧基查尔酮(16)、楝叶吴萸素B(17)、2′-羟基-3,4,5,4′,6′-五甲氧基查尔酮(18)、2′-羟基-3,4,4′,6′-四甲氧基查尔酮(19)、5,8-二羟基-6,7,3′,4′-四甲氧基黄酮(20)、3′-羟基-5,6,7,8,4′,5′-六甲氧基黄酮(21)、5,3′,5′-三羟基-7,4′-二甲氧基黄酮(22)、5,7,3′-三羟基-8,4′-二甲氧基黄酮(23)、3′-羟基-5,6,7,4′-四甲氧基黄酮(24)、5,7,3′,4′,5′-五甲氧基黄酮(25)、5-羟基-6,7,8,3′,4′-五甲氧基黄酮(26),其中化合物1、2为新化合物,化合物3~8、10~13、15、16、20~24为首次从九里香属植物中分离得到,化合物17为首次从千里香中分离得到。     

墨西哥落羽杉的化学成分

从墨西哥落羽杉(Taxodium mucronatum)枝叶中首次分离得到10个化合物,通过MS与NMR等方法将它们分别鉴定为quercetin 3′-methoxy-3-O-β-D-galactopyranoside(1),quercetin 3′-methoxy-3-O-β-D-arabinopyrano-side(2),quercetin 3′-methoxy-3-O-α-L-arabinofuranoside(3),quercetin(4),avicularin(5),quercetin 3-O-β-D-ga-lactopyranoside(6),(7′S,8′R)-4,7′-epoxy-3,3′-dimethoxy-4,9,3′,4′,9′-lignanepentol-4′-O-β-D-glucopyranoside(7),(7′S,8′S)-3,3′-dimethoxy-9,4′,9′-trihydroxy-4,8′-oxyneolignan-7′-O-β-D-glucopyranside(8),methyl shikimate(9)和β-sitosterol(10)。     

山敲骨的化学成分研究

从云南民间药用植物山敲骨(Pseuderanthemum latifolim(vahl)B.Hansen)的茎叶中分离得到8个化合物,经波谱分析鉴定为尿囊素(allantoin,1),7,4′-二羟基黄酮(7,4-′dihydroxyflavone,2),5,4′-二羟基-7甲氧基黄酮(5,4-′dihydroxy-7-methoxyflavone,3),5,6-二羟基-3′,4′,7,8-四甲氧基黄酮(5,6-dihydroxy-3′,4′,7,8-tetramethoxyflavone,4),sitoindosideΙ(5),antirrinoside(6),stigmasterol(7),stigmasterol-3β-O-glucopyranoside(8)。     

苏木化学成分的研究(Ⅰ)

从苏木(Caesalpinia sappan L.)70%乙醇提取物分离得到了8个化合物,利用现代波谱学方法鉴定其结构分别为5,7-二羟基-4′-甲氧基二氢异黄酮(1),鹰嘴豆芽素A(2),3,7,3′,4′-Tetrahydroxyflavanone(3),(αR)-α,3,4,2′,4′-Pentahydroxydihydrochalcone(4),Sappanone B(5),7,3′,4′?三羟基二氢异黄酮(6),7,3′,4′?三羟基二氢黄酮(7),7,3′,4′-三羟基异黄酮(8)。其中化合物1~4、6~8为首次从该属植物中分得的。     

海南栽培肾茶的化学成分研究

为了解肾茶(Clerodendranthus spicatus)的化学成分,从海南栽培肾茶地上部分分离得到11个化合物,经波谱分析分别鉴定为:吐叶醇(1)、丁香脂素(2)、3,4-二羟基苯乙醇(3)、甜橙素(4)、5,6,7,4′-四甲氧基黄酮(5)、5-羟基-6,7,3′,4′-四甲氧基黄酮(6)、6-羟基-5,7,4′-三甲氧基黄酮(7)、5-羟基-6,7,3′,4′-四甲氧基黄烷酮(8)、3,3′,5-三羟基-4′,7-二甲氧基-二氢黄酮(9)、松脂素(10)和熊果酸(11)。化合物3、9和10为首次从肾茶中分离得到。对化合物1~6进行活性测试,结果表明化合物3~5对乙酰胆碱酯酶具有一定的抑制活性。     

艾纳香化学成分的研究

从艾纳香(Blumea balsamifera DC.)中分离得到12个化合物,通过理化性质和波谱数据分析分别鉴定为;商路素(1),花椒油素(2),2,4-二羟基-6-甲氧基苯乙酮(3),5,7-二羟基色原酮(4),金丝桃苷(5),异槲皮苷(6),3′,4′,5,7-四羟基-3-甲氧基黄酮(7),槲皮素(8),槲皮素-3′-甲氧基-3-O-β-D-半乳吡喃糖苷(9),4′,5,7-三羟基-3,3′-二甲氧基黄酮(10),3,5,7-三羟基-3′,4′-二甲氧基黄酮(11),木犀草素(12).其中,化合物3-7和9- 11为首次从该属植物中分离得到.     

滑桃树种子的美登素类对小菜蛾的拒食作用

从云南省西双版纳的滑桃树种子中分离得到的特利回升,特利奴宁和特利福洛林等３个美登素化合物对小菜蛾有强烈的拒食作用。５０ｐｐｍ拒食效果分别为７１．５％,８６．７１％,８７．３７％;特利奴定１０ｐｐｍ对小菜蛾的拒食效果为５７．７１％;滑桃树种子的０．５％乙醇抽提物的拒食效果为６８．５％。     

小叶石楠中苷类化学成分的研究

从小叶石楠[Photinia parvifolia (Pritz.)Schneid]茎中分离得到10种化合物,利用波谱学方法分别鉴定为：（6′-O-palmitoly)-sitosterol-3-O-β-D-glucoside(1),isotachioside(2)、hexaacetate of (-)-lyoniresinol-3α-L-rhamnopyranoside(3a),koaburaside(4)、2,6-dimethoxy-4-hydroxyphenol-1-O-β-D-glucopyranoside(5),3-O-(β-D-glucopyranosyl)-1-(3′,5′-dimethoxy-4′-hydroxyphenyl)-1-propanone(6),di-O-methylcrenatin(7),L-threoguaiacylglycerol 8-O-β-glucopyranoside(8),苦杏仁苷（9）,D-threo-guaiacylglycerol 8-O-β-glucopyranoside(10)。以上10个化合物均为首次从该属植物中分离得到。     

苦槛蓝叶中的黄酮类化合物

为了解苦槛蓝(Myoporum bontioides A.Gray)的化学成分,采用色谱分离技术从苦槛蓝叶片中分离得到11个黄酮类化合物。通过波谱分析,他们的结构分别鉴定为:桔皮素(1)、甜橙素(2)、5,4′-二羟基-6,7,8,3′-四甲氧基黄酮(3)、4′,5,7,8-四甲氧基黄酮(4)、去甲基川陈皮素(5)、5-羟基-6,7,3′,4′-四甲氧基黄酮(6)、3′,4′,5,6,7,8-六甲氧基黄酮(7)、二氢山柰酚(8)、木犀草素(9)、3′,4′,5,7-四羟基-3-甲氧基黄酮(10)和芹黄素(11)。除化合物9之外,其他化合物均为首次从苦槛蓝叶片中分离得到。孢子萌发法测定结果表明,化合物1,2,8和9对香蕉炭疽菌(Colletotrichum musae)具有较好的抑菌活性。这为苦槛蓝叶片中有效成分的利用提供了理论依据。     

Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents

Searching for new antiobesity agents, a new series of fatty acid amide derivatives of 1,5-diarylpyrazole have been synthesized as dual peroxisome proliferator activated receptor alpha (PPARalpha)/cannabinoid receptor ligands. The compounds have been evaluated in vivo and in vitro as PPARalpha activators and as cannabinoids in two tests of the mouse tetrad. In vivo, food intake studies have been performed with all the compounds. No significant cannabinoid activity has been found but some compounds behaved as potent PPARalpha activators. Several compounds showed anorexigenic properties reducing food intake in rats.     

Synthesis and evaluation of new carbonic anhydrase inhibitors

A series of new sulfamide derivatives have been synthesized, their structures were confirmed by (1)H NMR and ESI-MS. Some target compounds were assessed by the tool of Dock6, and inhibition effects of all the new compounds on carbonic anhydrase II have been investigated. In addition, some compounds have been investigated for their antihypoxic effects in mice. Results indicated that nine target compounds exhibit as effectively as acetazolamide and 10 compounds have more potent inhibition effects on carbonic anhydrase II than acetazolamide. Three of them (I-8, I-18 and I'-3) can prolong markedly the survival time of mice in hypoxia, which are worth carrying out further studies.     

Biologically active secondary metabolites from myxobacteria

New chemical structures with proven biological activity still are badly needed for a host of applications and are intensively screened for. Suitable compounds may be used as such, or in the form of their derivatives or, equally important, may serve as lead compounds for designing synthetic analogs. One way to new compounds is the exploitation of new producer organisms. During the past 15 years the myxobacteria have been shown in our laboratories to be a rich source of novel secondary metabolites, many of the compounds showing interesting and sometimes unique mechanisms of action. About 50 basic structures and nearly 300 structural variants have been elucidated, and almost all of them turned out to be new compounds. Several myxobacterial substances may have a good chance of an application.     

New target for inhibition of bacterial RNA polymerase: 'switch region'

A new drug target - the 'switch region' - has been identified within bacterial RNA polymerase (RNAP), the enzyme that mediates bacterial RNA synthesis. The new target serves as the binding site for compounds that inhibit bacterial RNA synthesis and kill bacteria. Since the new target is present in most bacterial species, compounds that bind to the new target are active against a broad spectrum of bacterial species. Since the new target is different from targets of other antibacterial agents, compounds that bind to the new target are not cross-resistant with other antibacterial agents. Four antibiotics that function through the new target have been identified: myxopyronin, corallopyronin, ripostatin, and lipiarmycin. This review summarizes the switch region, switch-region inhibitors, and implications for antibacterial drug discovery.     

A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery

The discovery of new antimalarials with transmission blocking activity remains a key issue in efforts to control malaria and eventually eradicate the disease. Recently, high-throughput screening (HTS) assays have been successfully applied to Plasmodium falciparum asexual stages to screen millions of compounds, with the identification of thousands of new active molecules, some of which are already in clinical phases. The same approach has now been applied to identify compounds that are active against P. falciparum gametocytes, the parasite stage responsible for transmission. This study reports screening results for the Tres Cantos Antimalarial Set (TCAMS), of approximately 13,533 molecules, against P. falciparum stage V gametocytes. Secondary confirmation and cytotoxicity assays led to the identification of 98 selective molecules with dual activity against gametocytes and asexual stages. Hit compounds were chemically clustered and analyzed for appropriate physicochemical properties. The TCAMS chemical space around the prioritized hits was also studied. A selection of hit compounds was assessed ex vivo in the standard membrane feeding assay and demonstrated complete block in transmission. As a result of this effort, new chemical structures not connected to previously described antimalarials have been identified. This new set of compounds may serve as starting points for future drug discovery programs as well as tool compounds for identifying new modes of action involved in malaria transmission.     

Gold compounds as therapeutic agents for human diseases

The application of gold in medicine is traceable for several thousand years and Au(i) compounds have been used clinically to treat rheumatoid arthritis since the last century. Recently research into gold-based drugs for a range of human diseases has seen a renaissance. Old as well as new Au(i) and Au(iii) compounds have been used and designed with an aim of targeting cellular components that are implicated in the onset or progression of cancers, rheumatoid arthiritis, viral and parasitic diseases. In addition, new disease targets have been found for gold compounds that have given insight into the mechanism of action of these compounds, as well as in the molecular pathophysiology of human diseases. Here we discuss the rationale for the design and use of gold compounds that have specific and selective targets in cells to alleviate the symptoms of a range of human diseases. We summarise the most recent findings in this research and our own discoveries to show that gold compounds can be developed to become versatile and powerful drugs for diseases caused by dysfunction of selenol and thiol containing proteins.     

植物内生菌生物抗菌活性物质研究进展

植物内生菌作为一种新型的微生物资源,分离和确定其代谢产物是一条寻找新型天然活性物质的重要途径。目前为止,许多研究者从不同的植物内生菌中分离到大量具有抗菌活性的新化合物,这些新的化合物被认为是解决日益严重的微生物多重耐药性的希望之一。本文从植物内生菌的多样性、抗菌活性物质多样性及国内内生菌研究进展等多个角度概述了当前有关植物内生菌研究的主要成果和最新进展,以期为植物内生菌相关研究提供借鉴。     

Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents

The increase in the prevalence of multi drug-resistant and extensively drug-resistant strains of Mycobacteriumtuberculosis case demonstrates the urgent need of discovering new promising compounds with antimycobacterial activity. As part of our research program and with a aim of identifying new antitubercular drug candidates, a new class of 2-(trifluoromethyl)-6-arylimidazo[2,1-b][1,3,4]thiadiazole derivatives has been synthesized by both conventional as well as microwave assisted method and evaluated for their in vitro antitubercular activity against M. tuberculosis H(37)Rv. Moreover, various drug-likeness properties of new compounds were predicted. Seven compounds from the series exhibited good activity with MIC in range 3.12-1.56μg/ml. The present study suggests that compounds 6b, 6c, 6d, 6e and 6f may serve as promising lead scaffolds for further generation of new anti-TB agents.     

Design, synthesis, and biological evaluation of alcyopterosin A and illudalane derivatives as anticancer agents

The synthesis of alcyopterosin A and a series of new derivatives possessing an illudalane skeleton is described. The DNA binding properties of these compounds have been examined and compared to those of reference drugs using a UV spectroscopy technique. The antitumor activity of selected compounds against a panel of 60 human tumor cell lines was tested in the in vitro anticancer screening of the National Cancer Institute. Redox properties were also evaluated. Tested compounds showed significant DNA affinity, derivatives 6 and 15 exhibited remarkable antiproliferative activity and have been identified as new leads in the antitumor strategies.     

Effect of actoprotectors on Ca, Mg-dependent ATPase activity in the sarcoplasmatic reticulum of rabbit muscles

The effect of different chemical compounds on Ca, Mg-dependent ATPase (Ca-ATPase) sarcoplasmic reticulum (SR) hydrolytic activity as well as their actoprotecting (AP) activity, the ability to increase organism's resistance under muscle stress and antihypoxanthic (AH) activity to increase the organism's survival under conditions of low pressure has been studied. The compounds with AP-activity have been shown to be strong inhibitors of Ca-ATPase SR hydrolytic activity. No correlation between AP-activity of the compounds and their effect on Ca-ATPase SR has been found. The membranotropic activity of actoprotectors has been shown by electronic paramagnetic resonance method. A suggestion has been made to use Ca-ATPase SR as a tested object during the forecasting actoprotecting activity of new chemical compounds.